Background: The influence of type of dialysis on survival of patients with end-stage renal disease (ESRD) is controversial. Objective: To compare risk for death among patients with ESRD who receive peritoneal dialysis or hemodialysis. Design: Prospective cohort study. Setting: 81 dialysis clinics in 19 U.S. states. Patients: 1041 patients starting dialysis (274 patients receiving peritoneal dialysis and 767 patients receiving hemodialysis) at baseline. Measurements: Patients were followed for up to 7 years and censored at transplantation or loss to follow-up. Cox proportional hazards regression stratified by clinic was used to compare the risk for death with peritoneal dialysis versus hemodialysis. Results: Twenty-five percent of patients undergoing peritoneal dialysis and 5% of hemodialysis patients switched type of dialysis. After adjustment, the risk for death did not differ between patients undergoing peritoneal dialysis and those undergoing hemodialysis during the first year (relative hazard, 1.39 [95% CI, 0.64 to 3.06]), but the risk became significantly higher among those undergoing peritoneal dialysis in the second year (relative hazard, 2.34 [CI, 1.19 to 4.59]). After stratification, the survival rate was no different for patients who had the highest propensity of being initially treated with peritoneal dialysis. Results were consistent with adjustment based on a propensity score model and in sensitivity analyses that used as-treated models and models in which switches in type of dialysis were treated as treatment failures. Results were similar but stronger in analyses that were restricted to patients who were treated only in clinics offering both types of dialysis. Limitations: Patients were not randomly assigned to their initial type of dialysis. Also, more patients undergoing peritoneal dialysis than hemodialysis switched type of dialysis over time, and the reason for switching was often a consequence of the technique. Conclusions: The risk for death in patients with ESRD undergoing dialysis depends on dialysis type. Further studies are needed to evaluate a possible survival benefit of a timely change from peritoneal dialysis to hemodialysis.
机构:
China Med Univ Hosp, Kidney Inst, Taichung, Taiwan
China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan
China Med Univ, Dept Med, Taichung, TaiwanChina Med Univ Hosp, Kidney Inst, Taichung, Taiwan
Chou, Che-Yi
Liang, Chih-Chia
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ Hosp, Kidney Inst, Taichung, Taiwan
China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, TaiwanChina Med Univ Hosp, Kidney Inst, Taichung, Taiwan
Liang, Chih-Chia
论文数: 引用数:
h-index:
机构:
Kuo, Huey-Liang
论文数: 引用数:
h-index:
机构:
Chang, Chiz-Tzung
论文数: 引用数:
h-index:
机构:
Liu, Jiung-Hsiun
Lin, Hsin-Hung
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ Hosp, Kidney Inst, Taichung, Taiwan
China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan
China Med Univ, Dept Med, Taichung, TaiwanChina Med Univ Hosp, Kidney Inst, Taichung, Taiwan
Lin, Hsin-Hung
论文数: 引用数:
h-index:
机构:
Wang, I-Kuan
Yang, Ya-Fei
论文数: 0引用数: 0
h-index: 0
机构:
China Med Univ Hosp, Kidney Inst, Taichung, Taiwan
China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan
China Med Univ, Dept Med, Taichung, TaiwanChina Med Univ Hosp, Kidney Inst, Taichung, Taiwan
机构:
Nanjing Med Univ, Dept Pharm, Affiliated Wuxi Childrens Hosp, Wuxi, Jiangsu, Peoples R ChinaNaval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China
Zhu, Sang
Zhang, Feng
论文数: 0引用数: 0
h-index: 0
机构:
Naval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R ChinaNaval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China
Zhang, Feng
Shen, Ai-Wen
论文数: 0引用数: 0
h-index: 0
机构:
Naval Med Univ, Changzheng Hosp, Dept Nephrol, Shanghai, Peoples R ChinaNaval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China
Shen, Ai-Wen
Sun, Bo
论文数: 0引用数: 0
h-index: 0
机构:
Naval Med Univ, Changzheng Hosp, Dept Nephrol, Shanghai, Peoples R ChinaNaval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China
Sun, Bo
Xia, Tian-Yi
论文数: 0引用数: 0
h-index: 0
机构:
Naval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R ChinaNaval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China
Xia, Tian-Yi
Chen, Wan-Sheng
论文数: 0引用数: 0
h-index: 0
机构:
Naval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R ChinaNaval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China
Chen, Wan-Sheng
Tao, Xia
论文数: 0引用数: 0
h-index: 0
机构:
Naval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R ChinaNaval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China
Tao, Xia
Yu, Sheng-Qiang
论文数: 0引用数: 0
h-index: 0
机构:
Naval Med Univ, Changzheng Hosp, Dept Nephrol, Shanghai, Peoples R ChinaNaval Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China
机构:
Univ Nove Julho, UNINOVE, Sao Paulo, BrazilUniv Nove Julho, UNINOVE, Sao Paulo, Brazil
Goncalves, Thiago J. M.
Moyses, Rosa M. A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Nove Julho, UNINOVE, Sao Paulo, Brazil
Univ Sao Paulo, Hosp Clin HCFMUSP, Nephrol Div, Sao Paulo, BrazilUniv Nove Julho, UNINOVE, Sao Paulo, Brazil
Moyses, Rosa M. A.
Coelho, Fernando M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Fed Sao Paulo, Dept Neurol & Neurocirurgia & Psicobiol, Sao Paulo, BrazilUniv Nove Julho, UNINOVE, Sao Paulo, Brazil
Coelho, Fernando M.
Elias, Rosilene M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Nove Julho, UNINOVE, Sao Paulo, Brazil
Univ Sao Paulo, Hosp Clin HCFMUSP, Nephrol Div, Sao Paulo, BrazilUniv Nove Julho, UNINOVE, Sao Paulo, Brazil